Clinical Trials Directory

Trials / Completed

CompletedNCT06978595

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies: a Retrospective Cohort Based on SEER Database From 2000-2021

Status
Completed
Phase
Study type
Observational
Enrollment
8,171 (actual)
Sponsor
asmaa salama ibrahim · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This original research investigates the critical issue of gastrointestinal (GI) second primary malignancies (SPMs) in patients with signet ring cell carcinoma (SRCC), a rare and aggressive subtype of colorectal cancer. Utilizing the Surveillance, Epidemiology, and End Results (SEER) database, the investigators assessed the risk of GI SPMs, particularly within 2-11 months post-SRCC diagnosis.

Conditions

Timeline

Start date
2000-01-01
Primary completion
2021-12-30
Completion
2021-12-30
First posted
2025-05-18
Last updated
2025-05-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06978595. Inclusion in this directory is not an endorsement.

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies (NCT06978595) · Clinical Trials Directory